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Diabetes, depression and suicidal behavior are increasingly prevalent conditions with major
public health implications. A potential association between these conditions has been suggested
in the literature but not entirely explored. The Indigenous Canadian population is facing a
growing epidemic of diabetes, depression and suicidal behavior. Yet, this vulnerable population
is consistently under-represented in research that addresses mental health issues among patients
with diabetes. Therefore, this thesis aimed to: (a) systematically evaluate the association between
diabetes, depression, and suicidal behavior among the general population; and (b) assess the
inter-relationship between diabetes, depression, and lifetime suicidal ideation among Indigenous
Canadians living off-reserve. A systematic literature review and meta-analysis was conducted to
examine the associations of interest among the general population. It included 50 studies, 33
assessed depression, 14 suicidality and 3 studies assessed both. Meta-analysis results showed that
diabetic patients were at a significantly higher risk of depression compared to non-diabetics.
Additionally, patients with diabetes were at a significantly higher risk for experiencing suicidal
ideation and attempting suicide. However, there was not enough evidence to support an
association between diabetes and suicidal death. Epidemiological modeling of secondary data
from the Aboriginal Peoples Survey was used to examine the associations of interest among the
Indigenous Canadian population. The prevalence of depressive symptoms in the Indigenous
diabetics was 15.67% compared to 9.27% among the non-diabetic participants. After controlling
for socio-demographics, smoking/alcohol use/drug use, anxiety disorders and other chronic
illnesses diabetes was still significantly associated with depressive symptoms. The prevalence of
suicidal ideation in diabetics was 23.86% compared to 18.71% among the non-diabetic
participants. After adjusting for the effect of socio-demographics and health related behavioral
factors, diabetes was still significantly associated with a higher risk of reporting suicidal ideation.
However, after further adjusting for mental disorders (mood and anxiety) and other chronic
illnesses, the association was no longer significant. The increased risk of depression and
suicidality in diabetic patients among Indigenous peoples and the wider population highlights the
importance of integrating the screening and management of depression and suicidal behavior
with diabetes management in primary healthcare settings.
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CHAPTER 1 - INTRODUCTION
This introductory section provides background information on depression, suicidality, and
diabetes both in regards to the general and Indigenous populations. It also discusses the main
concept of this thesis, specifically as it pertains to the association between diabetes, depression
and suicidality within the general and Indigenous Canadian context. In addition, it outlines the
main objectives of this thesis work and discusses its significance to the field of public health.
1.1 Background
1.1.1 Depression
Depression is a mood disorder characterized by sadness, loss of interest or pleasure, feelings of
guilt or worthlessness, disturbed sleep or appetite, decreased energy, and poor concentration (1).
Depression can be long standing or recurrent, substantially impairing an individual’s ability to
function at work or school or cope with daily life. If severe, depression can lead to suicide (1).
Depression is a relatively common and increasingly more prevalent mental health disorder. In
2017, the World Health Organization (WHO) estimated that more than 322 million (4.4%) people
suffered from depression worldwide. Depression is associated with significant economic costs
due to loss of occupational productivity, use of medical treatments and healthcare services and
suicide related expenditures. It is ranked as the leading cause of global disability at 7.5% and
plays a major role in suicide deaths (1). In Canada, 11.3% of adults met the criteria for being
diagnosed with major depression, at some point in their lifetime, and 4.7% during the last 12
month (2). Besides the high prevalence, depression accounts for 6.9% of all years lived with
disability in Canada (1)
Generally, different clinical terms and classifications have been used for depression. The terms
that have been used interchangeably to describe depression include: depressive disorders, major
depressive disorder, unipolar depression, clinical depression, depressive episode, and depressive
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symptoms. The classifications that have been used in this thesis include: The International
Classification of Diseases, Tenth Revision, Clinical Modification (ICD-10) (3) and the American
Psychiatric Association Diagnostic and Statistical Manual of Mental Health (DSM-V) (4).
In DSM-V, major depression is defined as depressed mood or loss of interest/pleasure
(anhedonia), accompanied by five of the following symptoms: weight change, insomnia or
hypersomnia, psychomotor agitation or retardation, fatigue, feelings of worthlessness or guilt,
diminished concentration, and recurrent thoughts of death or suicide (4). In ICD-10, patient must
have at least two of the core symptoms (depressed mood, loss of interest, or reduction in energy),
and a minimum of two associated symptoms (loss of self-esteem, inappropriate guilt feeling,
decreased concentration, change in psychomotor activity, sleep disturbance, changes in appetite
with weight changes and recurrent suicidal thoughts) to be diagnosed with depression (3).
Both the DSM-V and ICD-10 diagnostic systems require symptoms to be present for at least 2-
weeks and to result in functional impairment in order to make a diagnosis of major depression.
Both systems further classify depressive episodes into mild, moderate and severe depending on
the number of symptoms, extent of social and occupational impairment, and interference with
daily life (3, 4). These classifications are typically used during a standard diagnostic interview
with a healthcare professional. Consequently, using these classifications for rigorous clinical
diagnosis could be time consuming and resource exhaustive.
Given the growing interest in depression research, there is a need to streamline and simplify how
depression is defined and diagnosed. Therefore, there is an increased acceptability in the use of
self-report questionnaires that measure depressive symptoms such as the Patient Health
Questionnaire (PHQ-9) or the Hospital Anxiety and Depression Scale (HADS) (5, 6). These tools
are based on symptom counts and assume that different symptoms weigh equally, ignoring the
pattern of depressive symptoms. Furthermore, they fail to account for variations in duration and
the degree of functional impairment (7). Despite these drawbacks, they are still considered to
provide good measures of the severity of depression, which has been proportionally related to the
number of symptoms (8). Moreover, the use of these questionnaires could prove useful for the
categorization of subclinical depressive symptoms, which refers to a depression that doesn’t fully
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meet the previously detailed clinical criteria of major depression. This category of depression has
been associated with significant morbidity and economic costs and represents a risk factor for
major depression (9).
In addition to self-report questionnaires, researchers have also used prescription of antidepressant
medications in order to help evaluate the presence of depression, especially in light of advances
and use of administrative healthcare data in research settings. This method may enable data
collection on large samples at lower costs, but it inevitably introduces some bias. Many patients
with depressive disorders may not receive pharmacological treatment (10). Whereas,
antidepressant drugs are prescribed for conditions other than depression (e.g. long-term pain,
anxiety and obsessive compulsive disorders).
1.1.2 Suicidality
Suicide1 represents a public health emergency worldwide (11). Globally, there are nearly 800,000
suicidal deaths every year, accounting for 1.4% of all deaths. This number is projected to steadily
increase through 2030 (12, 13). In Canada, the problem is equally acute with approximately
4,400 suicides reported annually, making it the ninth leading cause of death (14). However,
accurate accounts of suicide as a cause of death and reporting suicidal attempts are difficult to
confirm because of the social stigma associated with suicide (15). Consequently, the numbers
reported most likely underestimate the actual extent of the problem of suicidality.
Estimating the prevalence of suicidal ideation and attempts has proven to be challenging, as rates
vary widely in different populations and settings, and largely depend on the evaluation methods
used (16). One epidemiological study assessed data from 17 countries and reported a 9.2%
lifetime prevalence of suicidal ideation and 2.7% for suicidal attempts. They also observed that
60% of suicide ideators progressed to attempts within a 12-month period after ideation onset (17).
Another large study among the Chinese general population reported an estimate for lifetime
prevalence of suicidal ideation and attempts to be 3.9% and 0.8%, respectively (18). In Canada,
1 In this thesis, the term “suicidality” and “suicidal behavior” are used interchangeably to refer to suicidal ideation, suicidal
attempts, and suicidal death.
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12.1% of those 15 years or older reported having suicidal thoughts in 2015 (19).
Mental health disorders are a known risk factor of suicide death (20). In general, more than 90%
of suicidal deaths are associated with mental health disorders (21). Some of the most commonly
associated mental health illnesses include: major depression, bipolar disorders, post-traumatic
stress disorders, and drug abuse. Psychological predictors of suicide risk include: depressed mood,
hopelessness, and impulsivity, with the later acting as a facilitator for the progression from
ideation to attempt (22- 24).
1.1.3 Diabetes
Diabetes mellitus is a group of metabolic disorders characterized by chronic elevation in blood
glucose (hyperglycemia) due to defects in insulin secretion, action, or both (25). It is traditionally
classified into: type 1, type 2, gestational, and other genetic forms of diabetes mellitus (25). In
this thesis, we will focus mainly on type 1 and type 2 diabetes.
Type 1 diabetes typically affects younger age groups, mostly children and adolescents, and it is
characterized by autoimmune destruction of insulin producing cells leading to insulin deficiency
(26). Type 1 diabetes constitutes 5-10% of all diabetic patients and requires regular, daily insulin
injections, monitoring of blood glucose and a healthy lifestyle to control blood glucose levels. On
the other hand, Type 2 diabetes is the most common type of diabetes and accounts for 90% of all
diabetic patients. It usually affects adults and it is due to insulin resistance. Historically, type 2
diabetes is predominantly seen among adults. However, in recent years it has also been observed
at an increasing rate among children and adolescents, mostly due to their high rates of obesity,
sedentary lifestyle and unhealthy diet.
Typically, type 2 diabetes among adults has been strongly linked to a number of risk factors
including: obesity, aging, ethnicity, and family history (26). The critical step in the management
of type 2 diabetes is for the patients to adopt a healthy lifestyle and maintain a healthy body
weight. In more advanced cases, diabetics are required to take oral hypoglycemic agents and/or
insulin to control their blood glucose levels (26).
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Hyperglycemia, the hallmark of diabetes, is the leading cause of long-term damage to a number
of body organ systems that can broadly be subdivided on the basis of the micro and macro
vascular complications of diabetes. Micro vascular complications affect the eyes (diabetic
retinopathy), kidneys (nephropathy) and nerves (neuropathy), while the macro vascular
complications are mainly linked to an increased risk for cardiovascular diseases (stroke, coronary
artery disease, and peripheral vascular disease). Therefore, the micro and macro vascular
complications of diabetes are known to have the potential to cause blindness, kidney failure,
amputations, and cardiovascular diseases (27).
In 2017, the International Diabetes Federation reported that there were 425 million (8.8%)
diabetics worldwide. The number of diabetics is projected to increase by 48%, reaching 679
million people (9.9%) by 2045 with the majority of patients between the ages of 20-64 years old
(76.9%) (25). In 2017, more than 5 million deaths were attributable to diabetes, accounting for
10.7% of all global causes of mortality (26). In Canada, there were 3.4 million diabetics (9.3%) in
2015 and the number is expected to increase by 44% and reach 5 million people (12.1%) by 2025
(28). In Canada, the situation is particularly dire, when one considers that it has the third highest
rate of mortality due to diabetes among OECD2 countries with 18 deaths per 100,000 population
(29).
Diabetes and its medical complications place a significant economic burden on individual
patients, their families and national healthcare systems worldwide. The chronic nature of diabetes
and its complications cause substantial direct (mainly for hospital and institutional care, primary
care, and medications) and indirect costs (due to premature death and long term disability) (30).
Overall, there has been a remarkable increase in the estimates of healthcare expenditure on
diabetes from $232 billion United States Dollars (USD) in 2007 to $727 billion USD in 2017 (26).
In 2017, Canada was ranked among the top 10 countries worldwide in terms of total healthcare
2 The Organization for Economic Co-operation and Development (OECD) is an intergovernmental economic organization with
36 member countries, founded in 1961 to stimulate economic progress and world trade. It includes: Australia, Austria, Belgium,
Canada, Chile, Czech Republic, Denmark, Estonia, Finland, France, Germany, Greece, Hungary, Iceland, Ireland, Israel, Italy,
Japan, Korea, Luxembourg, Mexico, the Netherlands, New Zealand, Norway, Poland, Portugal, Slovak Republic, Slovenia, Spain,
Sweden, Switzerland, Turkey, the United Kingdom, and the United States.
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expenditure on diabetes by spending a reported $15 billion International Dollars3 (ID) and having
a mean healthcare expenditure per person with diabetes at $5,718 ID (26).
1.1.4 Depression, Suicidality, and Diabetes
Diabetes is a comprehensive disease that is not only associated with physical morbidities but also
with psychological ones (31). There is strong evidence to suggest that the prevalence of
depression among diabetic patients is significantly higher compared to non-diabetics (32- 34). In
a previous meta-analysis, the odds of depression in the diabetes group were two times higher than
the non-diabetes group (32). Other studies have also confirmed the higher risk of depression
among patients with diabetes (34). Depression significantly impacts the health of diabetic
patients leading to poor self-care, non-adherence to medical treatment, reduced quality of life,
higher rates of morbidity and mortality, and consequently, increased healthcare costs (33, 35).
Several plausible explanations have been proposed to account for the high co-morbidity between
diabetes and depression, and these include: (a) the commonality of environmental factors such as
low socio-economic status, which is known to play a role in the progression of both diabetes and
depression (36, 37); (b) the role of hyperglycemia and its link to activation of the Hypothalamic–
Pituitary Adrenal (HPA) axis, which in turn may predispose to depression (38); (c) the
similarities in the changes of the cerebral structure and blood flow that have been observed in
patients with diabetes and depression (39, 40); (d) the chronic inflammation and production of
inflammatory cytokines, a key feature of diabetes, which are also known to play a role in the
development and progression of depression (41); and (e) the use of different diabetic medications
that are reported to have a differential effect on the risk of diabetic patients potentially developing
depression (42, 43).
Depressive symptoms, especially hopelessness, may increase the risk of suicidal ideations in
diabetic patients (44). Suicidal ideation has also been linked to lack of compliance with medical
treatment, especially among diabetic patients (44). Although the association between diabetes and
depression has been extensively examined in the literature, the association of diabetes with
3 The International Dollar is a hypothetical unit of currency that has the same purchasing power parity that the U.S. dollar had in
the United States at a given point of time.
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suicidal behavior remains unclear and evidence at times can be conflicting (45- 48). For example,
most studies of suicidal ideations in patients with diabetes focused on young adults with type 1
diabetes and found an increased prevalence of suicidal ideation relative to the general population
(45, 46). However, among studies with older individuals suffering from type 2 diabetes, the
results have been less consistent (47, 48).
A multitude of factors play an important role in the intricately complex association between
diabetes, depression and suicidality. Some of the general risk factors of depression pertain to
diabetic patients such as female sex, young age, being single, and low socio-economic status (49).
Moreover, some risk factors related to diabetes are known to increase the risk of depression: (a)
the presence of diabetic complications, especially diabetic neuropathy (50, 51), and (b) being
treated with insulin, which is a marker for the progression of diabetes (52).
1.1.5 Indigenous Peoples
The United Nations estimates that there are 370 million “Indigenous people4” residing in 70
countries across the world and most notably in the Americas, Northern Europe, Australia, and
New Zealand. Indigenous peoples (also known as Aboriginal peoples) represent the descendants
of native inhabitants of the land before colonization and settlement took place. While there is no
existing uniform definition for Indigenous people, they are generally characterized by having a
historical continuity with pre-colonial and/or pre-settler societies with distinct social, economic
and political systems, cultures and beliefs (53).
The Canadian Constitution Act of 1982 (section 35) states that Indigenous peoples of Canada
include: First Nations (58.3%), Métis (35.1%), and Inuit (3.9%) peoples (54). First Nations are
recognized as the original inhabitants of the land of Canada. They represent a diverse group with
more than 600 First Nations bands and around 60 different languages (55). Almost three-in-four
First Nations identify as being Registered Indians (according to the Indian Act of Canada) (54).
4 In this thesis, the term “Indigenous people” and “Aboriginal people” are used interchangeably.
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Of all First Nations peoples, 38% live on-reserve5 and the remaining portion (62%) live off-
reserve mainly in major urban settings across Canada (56). Métis people trace their ancestry to a
mixed European and Indigenous origin and progressed to develop their own culture and traditions.
Inuit people are known to inhabit the northern regions of Canada. The Inuit home is known as
“Inuit Nunangat”, a term that refers to the land, water and ice in the Arctic region (55).
In 2016, there were approximately 1.7 million people who self-identified as Aboriginal,
accounting for 4.9% of the total Canadian population (54). In general, they are considered to be
the youngest and fastest growing sub-segment of the Canadian population. The growth rate
between 2006 and 2011 was quite remarkable with reports stating that the Indigenous population
was increasing at a rate four times higher than the one observed for their non-Indigenous
counterparts (20% vs. 5%) (57). The Indigenous population is also known to be significantly
younger than the non-Indigenous, with a median age of 28 years old compared to 41 years old for
the non-Indigenous population. This age difference is partially explained by the higher fertility
rates and shorter life expectancy for the Indigenous peoples in Canada (58).
The Indigenous Canadian peoples are known to generally have a poorer health profile compared
to the non-Indigenous Canadian population. They have significantly higher rates of chronic
diseases including diabetes and mental health disorders (59). Several factors have been
implicated in the health disparities observed among the Indigenous population, including: (a)
socioeconomic inequalities, (b) unfavorable physical environmental conditions, and (c)
significant barriers to accessing healthcare services (60).
Socio-economic inequities have been reported among Indigenous peoples in Canada with regard
to lower income, incomplete education, and higher rates of unemployment. In 2011, the National
Household Survey showed that the overall after-tax median income for Indigenous people was
$20,000 Canadian Dollars (CAD) compared to $27,000 CAD for their non-Indigenous
counterparts (61). Moreover, the proportion of persons aged 25-64 years old, who reported not
5 Under the Indian Act, an “Indian Reserve” is defined as “land held by the Crown “for the use and benefit of the respective
bands for which they were set apart” under treaties or other agreements. Reserves used as residences are referred to as ‘Indian
Bands’. The reserve system is connected to First Nations peoples who identify as Registered Indians. Inuit and Métis people
typically do not live on-reserves.
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having an educational certificate, diploma or degree was 29% in Indigenous people, whereas in
non-Indigenous people was 12% (62). Employment statistics were equally disconcerting and
showed that only 57.1% First Nations, 58.6% Inuit, and 71.2% Métis were employed compared
to 75.8% of non-Indigenous people (63).
Indigenous peoples face challenging physical environmental conditions in Canada. In 2016,
19.4% of the Indigenous people reported living in a house that was in need of major repairs
compared to only 6% of the non-Indigenous population (64). Significant barriers to accessing
healthcare services have also been observed, especially among remote, rural and on-reserve
communities, who also lack access to and experience difficulties in communicating with
healthcare providers in a timely manner (60).
Finally, systemic racism, social injustices and the institutionalization of practices (e.g. residential
schools) that undermine indigenous cultures and values have had a pernicious and persistent
effect on Indigenous health (65). Perhaps the best example is illustrated by the aggressive
assimilation of Indigenous children, who were removed from their families, communities and
cultures and were forced to attendant government sponsored residential schools run by the
Christian churches in Canada. It is believed that more than 150,000 Indigenous children attended
these schools between the time periods of the mid-1870s to mid-1990s (66). In the process, this
experience not only negatively impacted the mental and physical health of the survivors of these
residential schools but also that of their descendants, leading to inter-generational trauma (67)
1.1.6 Diabetes and Mental Illness in Indigenous People
Diabetes and mental illness were not known conditions among Indigenous Canadian people (68).
Colonization and assimilation resulted in significant changes to the food consumption habits,
social environment and economic structure of the Indigenous peoples. These changes were
associated with limited access to traditional food resources, loss of culture, erosion of traditional
practices and the undermining of the holistic approach to health by Indigenous peoples. This set
of prevailing conditions predisposed the Indigenous Canadian peoples to develop new illnesses
including the emergence of epidemics in diabetes and mental health illness (68).
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Diabetes is a widely prevalent chronic condition among the Indigenous Canadian peoples. The
Public Health Agency of Canada (PHAC) reported age standardized prevalence rates for diabetes
of 17.2% among First Nations living on-reserve, 10.3% off-reserve and 7.3% among Métis,
compared to 5% in the general population (69). Among the Indigenous Canadian population,
diabetes (especially type 2) increasingly affects younger age groups and in particular, children
and adolescents. It is estimated that the prevalence of type 2 diabetes is nearly 11% among First
Nations children, younger than 10 years old (70). If one takes into consideration the early onset
of diabetes and its longer exposure to hyperglycemia, it is not surprising to find that diabetes is
associated with higher rates of co-morbidities and complications in Indigenous peoples (71).
Indigenous Canadian populations have some of the highest suicide rates worldwide. First Nations
experience suicide rates that are two-times the national average and those observed among the
Inuit population are even higher, at 6 to 11-times (72). In 2012, 24% of First Nations living off-
reserve, 23.5% of Inuit and 19.6% of Métis people reported having lifetime suicidal thoughts,
compared to 11.1% in the general Canadian population (73).
Historical social injustices with the subsequent struggles of the Indigenous Canadian peoples,
represented in the loss of land, lack of self-governance, discrimination, marginalization, and
residential schools (65), made an indelible impact on their lives and led to serious detrimental
effects on their mental health. Elias et al. examined suicidal behavior among residential school
survivors and their off-spring and determined that both suicidal ideation and suicidal attempts
were consistently associated with the history of abuse even for non-attendees, supporting the
evidence for an intergenerational traumatic effect (67).
The limited data suggest that the Indigenous Canadian people experience greater rates of
depression relative to non-Indigenous population. Data from national surveys show that
Indigenous people living off-reserve were 1.8 times more likely to experience depressive
episodes in the past year compared to non-Indigenous people (74). Another survey assessing
major depression among First Nations living on-reserves found that 14% had major depression,
compared to 8% of the general Canadian population (72). However, examination of the literature
revealed a significant gap in recent and updated health information available for depression
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among First Nations, Métis, and Inuit peoples.
1.1.7 Depression and Suicidality among Diabetic Indigenous Peoples
Most Indigenous focused research is dedicated to health status and life style behavior. In general,
there is a shortage of research assessing other aspects of Indigenous peoples’ health (75). In
Canada, Barton et al., assessed health related quality of life and found that Indigenous
participants reported lower scores than non-Indigenous and diabetes was more prevalent among
Indigenous (76). With the overall scarcity of Canadian research assessing mental health in
Indigenous diabetic patients, Australian studies have taken the lead in exploring this important
research topic in recent years. Davis et al. evaluated the prevalence of depression between urban
Indigenous and Anglo-Celtic diabetic patients and showed that the prevalence of depression in
Indigenous participants was double that of the Anglo-Celtic. Furthermore, among Indigenous
participants, depression tended to be major and untreated (77).
It has also been suggested that Indigenous diabetic patients are under-screened for depression in
primary healthcare settings. A previous study evaluated depression among Indigenous individuals
in primary healthcare settings and concluded that overall, there was a lack of attention to
screening and evaluating depression, especially among those patients with more severe disease or
poor physical health, as often seen with Indigenous people. The authors explained this finding by
using the theory of competing demands, whereby physical illnesses exert strong competition and
take precedent over the screening and initiation of mental health care including depression (78).
However, there is also the possibility of institutional and systemic racism that leads to disparate
treatment within the healthcare setting on the basis of patients’ socio-cultural differences and in
turn, creates issues of trust and acceptance of mental health services by Indigenous patients (79).
1.2 The problem
The link between diabetes, depression and suicidality has not been fully explored and the limited
research in this important area provides evidence that is unclear and at times, conflicting. There is
a significant gap in the literature regarding the systematic review and assessment of suicidality in
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patients with diabetes and a real public health need to accurately estimate its prevalence among
diabetic individuals.
The Canadian literature on the relationship between diabetes and mental health in Indigenous
peoples is scarce. There is marked shortage in our collective knowledge regarding the extent of
the problem of depression and suicidality among our diabetic Indigenous Canadian peoples.
Therefore, this thesis has a two-fold aim: (1) to systematically evaluate the association between
diabetes, depression, and suicidal behavior among the general population; and (2) to assess that
inter-relationship between diabetes, depression, and lifetime suicidal ideation among Indigenous
Canadians living off-reserve.
1.3 Objectives
The main objectives of this thesis are:
1) To conduct a systematic review, synthesis and meta-analysis of the evidence among diabetic
patients in order to:
(a) Assess the risk of depression;
(b) Estimate the prevalence of suicidal ideations, attempted suicide, and completed suicide;
(c) Evaluate the association between suicidality and diabetes.
2) To use data from the Indigenous Peoples Survey to:
(a) Determine the prevalence of depressive symptoms and suicidal ideation among
Indigenous Canadian patients with diabetes;
(b) Investigate whether diabetes is associated with higher risk of depression and suicidal
ideation;
(c) Assess whether that association varies by different risk factors among the Indigenous
Canadian populations living off-reserve.
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1.4 Relevance
An association between diabetes, depression and suicidality would suggest the need to design and
implement culturally appropriate and comprehensive health promotion initiatives among this
marginalized population to help reduce and prevent their increased vulnerability for depression
and suicidality. The findings of the present study can help guide efforts for best practices in the
early detection and effective screening of depression and suicidality among diabetic patients in
primary healthcare settings.
1.5 Significance
This study is of great significance to both the general and Indigenous Canadian population.
There is a significant gap in literature that methodically assesses suicidality in patients with
diabetes. Moreover, the Indigenous Canadian population has consistently demonstrated a higher
prevalence of diabetes and depression, suicidal ideation and suicidal attempts. However, there is
scarcity of research in this important area that sheds light by investigating these relationships
among the Indigenous Canadian peoples.
1.6 Conclusion
Diabetic Indigenous experience significant challenges that increase their risk for depression,
suicidal ideation and suicidal attempts. Depression is a known co-morbidity for diabetes and it is
oftentimes undiagnosed. This is unfortunate, because currently many effective treatment
strategies exist for depression that can make a significant relevant difference in the lives of those
affected. Early treatment for depression may help curb the epidemic of suicidal ideation and
suicidal attempts among Indigenous peoples suffering from diabetes.
Establishing a better understanding of the risk profile of diabetic patients in general and those of
Indigenous descent in particular, can prove useful in properly assessing cases of depression and
suicide ideation and help reduce the rates of suicide attempts and suicides in Canada. The
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findings of this study help to highlight the importance of integrating the evaluation and treatment
of depression with diabetes management in primary healthcare settings and better inform future
policy and health promotion initiatives to d screen, diagnose and treat high-risk individuals
leading to improved health and better quality of life.
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CHAPTER 2 - RISK OF DEPRESSION AND SUICIDALITY AMONG DIABETIC PATIENTS:
A SYSTEMATIC REVIEW AND META-ANALYSIS
2.1 Abstract
Background and Rationale: Depression is commonly seen among diabetics and negatively
impacts their compliance with medical treatment, quality of life, morbidity and mortality.
Suicidality (suicidal ideation, suicide attempts, and completed suicide) has also been reported to
be more prevalent among diabetics. The purpose of this study is to conduct a systematic review
and meta-analysis to evaluate the risk of depression and suicidality among diabetic patients.
Methods:Medline, PubMed, EMBASE, Cochrane library, and Psych INFO were searched for
studies published from 2008 onwards. Two reviewers assessed the eligibility of each study based
on pre-specified inclusion criteria. Meta-analysis was conducted to estimate the pooled effect size.
Sources of heterogeneity were investigated through subgroup analysis and meta-regression.
Publication bias was assessed using funnel plot and Egger’s test.
Results: A total of 5,750 articles were identified and of those, 17 studies focusing on suicidality
and 36 on depression were included in this study. Our analysis suggests a positive relationship
between diabetes and depression. The pooled OR based on cohort studies was 1.49 (95% CI:
1.36-1.64) and for cross-sectional studies was 2.04 (95% CI, 1.73-2.42). The prevalence of
suicidal ideation, attempts, and completed suicide was 16.2%, 2.7%, and 0.3%, respectively.
Pooled OR for suicidal ideation, attempted, and completed suicide was 1.89 (95% CI: 1.36- 2.63),
1.45 (95% CI: 1.07- 1.96), and 1.85 (95% CI: 0.97-3.52), respectively. All findings were
statistically significant except for completed suicide.
Conclusion: The increased risk of depression and suicidality in diabetic patients highlights the
importance of integrating the evaluation and treatment of depression with diabetes management
in primary healthcare settings. Further studies are needed to confirm results from this meta-
analysis.
Keywords: Diabetes; Depression; Suicide; Suicidal ideation; Suicidal attempts; Suicidal death
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2.2 Introduction
Diabetes is considered one of the largest global epidemics and constitutes a public health
emergency in many countries (1). The global prevalence of diabetes among adults has nearly
doubled in the last couple of decades, rising from 4.7% in 1980 to 8.5% in 2014, resulting in
approximately 1.6 million deaths, annually (2). Diabetes is psychologically demanding given the
chronic and large burden placed on diabetics for the self-management of their disease. Diabetic
patients face several psychological challenges as a result of their illness, which may include:
adherence to medical treatment and lifestyle modifications, need for continued monitoring for
glycemic control, concerns for complications and disabilities, interference of symptoms with
daily activities and psychosocial difficulties at personal and interpersonal levels (3), all of which
may eventually lead to depression and in some cases suicide.
Depression is a common mental illness that negatively impacts productivity and quality of life (4).
It is reported that patients with depression die 5-10 years earlier than those without depression (5).
Evidence suggests that the co-morbidity of depression and diabetes is relatively common (6, 7, 8).
A previous meta-analysis estimated the prevalence of depression to be twice as high among
diabetics compared to the general population (6). Other systematic reviews corroborated these
findings and demonstrated a significantly higher risk for diabetic patients to develop depression
compared to non-diabetics (7, 8).
The co-morbidity between diabetes and depression is associated with poorer prognosis and higher
medical expenditures than either condition alone (9). This is an expected finding as depression
significantly impacts diabetic patients leading to poor self-care, non-adherence to medical
treatment, reduced quality of life, higher rates of morbidity and mortality, and consequently,
increased healthcare costs (10, 11). Additionally, depression among diabetic patients tends to last
longer and has higher recurrence rates compared to non-diabetics (12). Consequently,
identification of depression among diabetic patients is critically important to mitigate these
negative personal consequences and realize cost-savings in healthcare.
Suicide was responsible for more than 800,000 deaths per year in 2015 and is the second leading
cause of death among those aged 15 to 29 years old worldwide (13). Depressive symptoms may
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increase the risk of diabetic patients displaying suicidality (14), which may include: suicidal
ideation, attempted suicide, and completed suicide. Although the association between diabetes
and depression has been previously examined, the association with suicidality remains unclear
and the evidence is limited and at times, conflicting (15-17).
There is a significant gap in the literature regarding the systematic assessment of depression and
suicidality in patients with diabetes. To the best of our knowledge, the present study is one of the
first meta-analyses of its kind. The purpose of this study was to conduct a systematic synthesis
and meta-analysis of the evidence in order to: (1) assess the risk of depression (including clinical
depression, depressive symptoms, and use of antidepressants); (2) determine the prevalence of
suicidality; and (3) evaluate the risk of suicidality among diabetic patients.
2.3 Methods
2.3.1 Data sources and search strategies
A systematic literature search was undertaken using five relevant databases: PubMed, Medline,
EMBASE, Psych INFO, and Cochrane Library. Search strategies focused on three major domains:
(a) diabetes; (b) depression or suicidality; and (c) quantitative outcome measures. A combination
of keywords was used for the search and it included the following: (((("diabetes mellitus"[MeSH
Terms]) OR "diabetes mellitus, type 1"[MeSH Terms]) OR "diabetes mellitus, type 2"[MeSH
Terms])) AND ((((((("depression"[MeSH Terms]) OR "depressive disorder"[MeSH Terms]) OR
depressive symptoms [MeSH Terms]) OR "suicide"[MeSH Terms]) OR "suicide,
attempted"[MeSH Terms]) OR suicidal ideation [MeSH Terms]) OR suicide thoughts [MeSH
Terms])
2.3.2 Eligibility criteria and study selection
In our study, eligible articles were required to: (a) be published in the English language; in peer-
reviewed journals since 2008; and available in full text; (b) assess patients with type 1 and/or
type 2 diabetes mellitus, who either self-report a physician diagnosis of diabetes; or were
prescribed anti-diabetic medications; or were participants in studies using lab based assessments;
and (c) evaluate depressive disorders, or use of antidepressants or depressive symptoms based on
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validated standardized questionnaires. Studies were also selected by scanning the reference lists
of previous systematic reviews on the topic.
Articles had to have a comparative study design and provide sufficient data to calculate odds ratio
for depression among diabetics. For suicidality, single group studies in diabetic patients were
eligible for inclusion. Studies that explicitly assessed patients with gestational or genetic forms of
diabetes were excluded, as were studies for children younger than 11 years old. Studies were also
excluded, if they did not contain sufficient data to estimate the effect size. Eligible articles were
identified through title and abstract screening, followed by full text review. Two reviewers, RE
and SE, independently evaluated studies for relevance in a standardized manner. Non-agreement
was resolved by JM through discussion and adjudication.
2.3.3 Data extraction
Data extraction strategies were developed and pilot-tested on 20 randomly selected included
studies and then modified accordingly. Information extracted in duplicate from studies included:
author, publication year, country, study design, follow-up time (for cohort studies), settings, total
number of participants, age and sex of study participants, method of diabetes evaluation, method
of depression or suicidality assessment, reported effect measure with 95% confidence interval,
and covariates for adjusted effect measures.
Unadjusted odds ratios and 95% confidence intervals were calculated using the number of events
in the exposed and non-exposed groups. Odds ratios for depression were calculated for cohort
studies using cumulative incidence in the exposed compared to the non-exposed group. When
crude numbers were not available, we used the least adjusted effect measure reported by the
authors.
2.3.4 Risk of bias
Two reviewers (RE and SE) independently assessed the validity of eligible studies by using a
modified version of the Newcastle Ottawa Scale (NOS) (18). The NOS assesses
representativeness of the study sample, comparability between respondents and non-respondents,
ascertainment of depression or suicidality, and thoroughness of the reported descriptive statistics.
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Studies were rated as having a low, moderate or high risk of bias. Disagreements were resolved
by a third reviewer (JM) through consensus.
2.3.5 Data analysis
Statistical analysis was performed using the Comprehensive Meta-analysis software-version 3
(CMA-3) (19). For depression, pooled odds ratios (both adjusted and unadjusted) were the effect
measure of interest. While for suicidality, both odds ratios and pooled prevalence among
diabetics were the focus of our analysis. As heterogeneity was likely to exist, a random effect
model was used to calculate pooled estimates, which allows for estimating both within and
between studies variation. We examined heterogeneity using the Cochran’s Q heterogeneity test
and I2 as a measure for inconsistency (20).
To investigate possible explanations of heterogeneity, subgroup analysis and meta-regression
were conducted. For depression, pre-specified moderator variables included: geographical
location of the study, percent of female participants, method of depression evaluation (disorders,
symptoms, or antidepressants), whether diabetes was prevalent or incident, comparison group
(normo-glycemic or non-diabetic), and risk of bias for each individual study. For suicidality,
moderator variables also included: study design, type of diabetes as (type 1, type 2 or not
specified), and level of adjustment (no, partial [less than five confounders], or full [greater than
five confounders]).
Influential analysis was conducted for the effect of each study on the pooled estimate by
reassessing estimates after removal of one study at the time. To visually assess for publication
bias, the funnel plot method was used. The Egger’s regression intercept method was also used to
confirm and statistically test for the bias observed in the funnel plot (21). When publication bias
was detected, a Duval and Tweedie trim and fill method was used to calculate the adjusted effect




The PRISMA flow chart depicting the study selection is shown in Figure 2.1. A comprehensive
search of the literature yielded a total of 5,750 articles from which 1,733 were removed either for
being duplicates or published before 2008. This left 4,018 articles for screening. After initial
screening for titles and abstracts, 427 articles qualified for full text screening of which 355 were
excluded due to one or more of the following conditions: (a) their full text was not available; (b)
were not written in English; (c) focused on special populations; and/or (d) reported inadequate
data or mixed outcomes. In total, 50 studies were analyzed, with 33 reporting data only on
depression, 14 only on suicidality, and three studies reporting data on both depression and
suicidality among diabetic patients (23, 24, 25).
2.4.2 Risk of Bias
All cohort studies assessing depression among diabetic patients were classified as either low or
moderate in terms of the risk of bias except for one study, which was classified as having a high
risk of bias. Among cross-sectional studies assessing depression, seven were classified as low
risk of bias, 15 were moderate and two studies had a high risk of bias. For studies assessing
suicidality, 14 were rated as having low risk of bias, 11 moderate, and one as high risk of bias.
2.4.3 Study Characteristics
3.1 Depression
Depression studies were stratified and examined on the bases of their study design. Table 2.1 and
2.2 include summary of the characteristics of depression studies included in the review
A. Cohort studies
There were 12 cohort studies included for depression. One study (26) reported two datasets for
patients with prevalent and incident diabetes, leaving a total of 13 datasets for analysis. Three
studies (27, 28, 29) used incident prescription of antidepressants as a proxy for depression
diagnosis, five studies (26, 30, 31, 32, 33) used clinical diagnostic criteria, and three (34, 35, 36)
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relied on questionnaires. One study used both questionnaires and prescription of antidepressants
(34). Follow-up period ranged from two (26) to 15 years (28). Most studies were from Europe or
North America while only two studies were from Asia (30, 31). Ascertainment of diabetes was
made by physician diagnosis (ICD code) (26, 28, 30, 31, 32, 35), use of anti-diabetic medications
(27, 29, 35), self-reported diagnosis of diabetes (36, 37), and/or lab assessment (34, 35).
B. Cross-sectional studies
There were 23 cross-sectional studies and one case-control study (38) on depression and diabetes.
Additionally, three of these studies reported data on suicidality (23, 24, 25). Depression was
evaluated by: (a) questionnaires; (b) clinical diagnostic criteria (9 studies) (38, 39, 40, 51, 23, 42,
43, 44, 24); and (c) utilization of antidepressants (one study) (45). Two studies (39, 41) used both
depressive disorders and symptoms but for the analysis we used only results for depressive
disorders.
3.2 Suicidality
Suicidality was stratified and examined on the bases of outcome. Table 2.3 and 2.4 include
summary of the characteristics of suicidality studies included in the review
A. Completed suicide
Seven studies reported data on completed suicide (all cohort). Suicidal death was confirmed by
either ICD codes or examination of death certificate.
B. Suicidal attempts
Five studies assessed suicidal attempts and self-harm (one cohort, one nested case-control and
three cross-sectional). Attempted suicide was evaluated based on either ICD codes or self-
reported information.
C. Suicidal ideation
Twelve cross-sectional studies examined suicidal ideation. Three of them evaluated type 1
diabetics, one study evaluated type 2 diabetic patients, who were on insulin (24), while the
remaining studies included both type 1 and type 2 patients. Two studies had minors as
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participants (adolescents) (17, 46). All studies used self-reported information to evaluate for the
presence of suicidal ideation.
2.4.4 Main meta-analysis results
4.1 Depression
Depression results are reported as odds ratios (adjusted and unadjusted) by study design.
The overall OR based on all depression studies (cohort and cross-sectional) was 1.79 (95% CI:
1.62-1.99), with significant heterogeneity (I2= 98.09%, Q-value= 9.66, and p-value < 0.001).
Estimated odds ratios for the cohort and cross-sectional studies were significantly different (p-
value=0.002).
A. Cohort studies
The pooled unadjusted odds ratio for the association between diabetes and depression calculated
based on all 13 studies, using a random effect model was 1.49 (95% CI: 1.36-1.64, p-value
<0.001). Forest plot of the OR and 95% CI for the random effect model are shown in Figure 2.2.
There was significant heterogeneity between studies (I2= 94.08%, Q= 203.12, p-value < 0.001).
All standardized residuals were between the values of 3 and -3, suggesting no potential outliers.
The pooled adjusted effect estimate was calculated based on 5 studies (27, 34, 35, 36, 37) with an
OR= 1.48 (95% CI: 1.16-1.88) and p-value= 0.001. The test for heterogeneity was not significant
(I2=54.2%, Q= 8.73, p-value= 0.068).
B. Cross-sectional studies
Unadjusted odds ratio for depression among diabetics, calculated based on cross-sectional studies
was 2.04 (95% CI: 1.73-2.42) p-value <0.001. However, there was a significant heterogeneity
(I2=93.79%, Q= 370.7, p-value < 0.001). Adjusted odds ratio from cross-sectional studies was




Suicidality results are reported as prevalence and odds ratios (adjusted and unadjusted) stratified
by outcome.
A. Completed suicide
Overall prevalence was 0.3% (95% CI: 0.1 – 0.7%). Based on the five included studies (47, 48,
49, 50, 51), the unadjusted pooled odds ratio was 1.85 (95% CI: 0.97- 3.52, p-value= 0.061)
(Figure 3.2), with significant heterogeneity (I2= 94.79%, Q-value= 76.88, p-value <0.001).
Adjusted OR (based on three studies) was 1.39 (95% CI: 0.82-2.35, p-value 0.225) (I2= 81.66%,
Q= 10.90, p-value= 0.004).
B. Suicidal attempts
The pooled prevalence of attempted suicide was 2.7% (95% CI: 0.9 – 7.8%). Three studies
reported unadjusted odds ratios. The calculated unadjusted pooled odds ratio was 1.45 (95% CI:
1.07-1.96, p-value= 0.017) (Figure 3.2), with significant heterogeneity (I2= 53.43%, Q= 4.29, p-
value= 0.117). Adjusted odds ratio based on two studies (23, 52) was 1.33 (95% CI: 1.09-1.62, p-
value=0.005) (I2=0%, Q= 0.23, p-value= 0.635).
C. Suicidal ideation
The prevalence of suicidal ideation, among diabetics was 16.2% (95% CI: 8.5 - 28.5%).
Unadjusted pooled odds ratio (based on six studies) was 1.89 (95% CI: 1.36- 2.63, p-value
<0.001) (Figure 3.2), with significant heterogeneity (I2= 94.09%, Q-value= 84.65, p-
value<0.0001). One study (24) had high-standardized residual (of 3.36), so it was considered as
an outlier. After exclusion of this study, heterogeneity improved (I2 was reduced to 63.7%), but it
remained significant (p-value= 0.026), and the new pooled estimate for suicidal ideation was 1.49
(95% CI: 1.40, 1.60). Adjusted odds ratio (based on four studies) was 1.49 (95% CI: 1.14-1.96, p-
value= 0.004) (I2= 80.37%, Q= 15.28, p-value= 0.002).
29
2.4.5 Subgroup analysis and meta-regression
5.1 Depression
A. Cohort studies
To explain the significant heterogeneity, several subgroup analyses and meta-regressions were
conducted. In the six studies that evaluated depression among diabetics using clinical diagnostic
criteria, the pooled OR was 1.59 (95% CI: 1.35-1.86) and the test of heterogeneity was
significant (I2= 88.09%, Q=41.98, p-value <0.001). In the four studies that evaluated depression
among diabetics using questionnaires, the pooled OR was 1.41 (95% CI: 1.17-1.69), while the
test of heterogeneity was not significant (I2=9.24%, Q=3.30, p-value= 0.340). For the three
studies that used antidepressants, the pooled OR was 1.36 (95% CI: 1.19-1.54) and test of
heterogeneity was significant (I2=97.32%, Q=74.52, p-value <0.001). Studies were stratified on
the basis of assessing patients with incident diabetes OR=1.49 (95% CI: 1.33-1.69) and prevalent
diabetes OR=1.47 (95% CI: 1.25-1.72). Other confounders (level of adjustment, comparison
group, risk of bias, and geographical location) did not significantly impact the effect estimate.
Results for meta-regression are included in Table 2.5.
B. Cross-sectional studies
In evaluating depression, the same pattern observed for cohort studies was maintained in cross-
sectional studies. In examining the differences between groups, depressive disorders (OR= 2.24,
95% CI: 1.46-3.45), depressive symptoms (OR=1.47, 95% CI: 1.37-1.57), and antidepressants
(OR= 1.89, 95% CI: 1.86-1.92) were not statistically significant (p-value= 0.738).
5.2 Suicidality
The results for suicidality subgroup analysis are included in Table 2.6. Due to the limited number
of studies assessing attempted suicide, no subgroup analysis was conducted for that particular
outcome.
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2.4.6 Influential analysis and publication bias
Influential analysis revealed that no single study had a substantial influence on either the adjusted
or unadjusted effect estimates. There was evidence of publication bias for depression among
cohort studies based on the inspection of the funnel plot (Figure 2.4) and Egger’s test (p-
value=0.027). To account for this bias, a Duval and Tweedie test was used and reported an
adjusted OR 1.25 (95% CI: 1.15- 1.37). There was no evidence of publication bias for depression
among cross-sectional studies (p-value=0.721) and suicidality studies (p-value = 0.860).
2.5 Discussion
To our knowledge, this study is one of the first meta-analyses that reports the prevalence of
suicidality among diabetic patients and assesses the association between diabetes, depression, and
suicidality using data from observational studies. Our results show that diabetic patients are more
likely to have depression, experience suicidal ideations and attempt suicide compared to non-
diabetic patients. The findings of this study help highlight diabetics as a high-risk group for
depression and suicidality.
In regards to depression, based on 13 cohort studies and 23 cross-sectional studies, our results
suggest that there is a significant association between depression and diabetes. It is interesting to
note that this association maintained its strength even after adjusting for potential confounders.
Previous systematic reviews have shown that patients diagnosed with diabetes are at higher risk
for depression (7, 53). Similarly, our analysis of cohort studies corroborates the existing evidence
(53) and suggests a directionality, whereby diabetes may play a causal role in the development of
depression.
The psychological burden of diabetes may lead to but does not fully account for the increased
risk of depression (3). Other potential physiological contributors include: activation of the
hypothalamic pituitary adrenal axis (54, 55), chronic inflammation (56) and cerebral vascular
changes induced by diabetes (57). Additionally, some common medications used for the
treatment of diabetes have been linked to a higher risk of depression (58,59).
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In our study, the calculated odds ratio for cross-sectional studies (assessing prevalence of
depression) was higher than the one in cohort studies (assessing incidence of depression),
corroborating the results reported in a previous meta-analysis (6). This finding may be explained
in part by: (a) the longer duration of depression among diabetic patients and (b) the potential
bidirectional association between diabetes and depression.
The longer duration of depression among diabetic patients may be due to the increased likelihood
to experience treatment resistant and recurrent forms of depression (12). This leads to a build up
of chronic cases. The potential bidirectional association between diabetes and depression has also
been examined in the literature (34, 60). Depression has been linked to the development of type 2
diabetes with the use of certain antidepressants, which are known to have clinical effects on
glucose homeostasis and weight gain (61). Additionally, depression may have a negative effect
on a patient’s lifestyle choices including physical activity, leading to an increased risk to develop
diabetes (62). Thus, it is unsurprising that the risk of prevalent depression was higher than that of
incident depression among diabetic patients in our study.
Suicidality among diabetic patients has not been fully elucidated. This study examined the
prevalence and risk of suicidality among diabetic patients in order to address the existing gap in
the literature. In the general population, a study involving 17 countries found the lifetime
prevalence of suicidal ideation and attempts to be at 9.2% and 2.7%, respectively (63). By
comparison, our study found that the prevalence of suicidal ideation among patients with diabetes
was much higher at a reported 16.2% (95% CI: 8.5 – 28.5%), while the rate of attempted suicide
was similar at 2.7% (95% CI: 0.9 – 7.8%).
Depression is one of the leading risk factors for suicidality (14, 64). In our study, diabetic
patients were found to be twice as likely to experience suicidal ideations compared to non-
diabetics. When examining attempted suicide, diabetics were also significantly at higher risk
compared to non-diabetics. These findings are concerning and help highlight the vulnerability of
diabetic patients possibly progressing from suicidal ideation to attempted suicide.
32
In this study, despite the increased risk of suicidal ideation and attempts, diabetic patients did not
experience a significant risk of suicidal death (OR=1.85, 95% CI: 0.97- 3.52, p-value= 0.061).
This could be attributed to several reasons connected to suicide, including: (a) stigmatization; (b)
misclassification; (c) low occurrence; (d) limited details and number of studies; and (e) lack of
research into the distinct predictive factors for suicidal death.
Stigma related to suicide is a major barrier in accurately reporting and tracking of suicidal deaths
(65). The high level of stigmatization in many countries, where suicide is considered to be
immoral and illegal, might lead to underreporting of suicide as a cause of death (66). This in turn
would negatively impact accuracy of suicide rates reported in large-scale epidemiological studies
(66). Misclassification of suicidal death due to insulin overdoses as accidental death or death due
to natural causes is another possibility that need to be further evaluated. Studying suicide is also
statistically challenging because of the relative low occurrence of the event and the need for large
samples to obtain reliable estimates (67). Additionally, in the present systematic review, the
limited number of studies assessing suicidal attempts lacked some key details. For example, there
was dearth of information assessing the seriousness of the attempt (i.e. extent of hospital care
required afterward or whether the attempt resulted in permanent disabilities). Furthermore, it has
been suggested in the literature that suicidal ideations and behaviors might have different
predictors than completed suicide (68, 69). Therefore, we cannot fully rely on suicidal ideations
to understand completed suicide. Factors that may play a role in moving from one condition to
another remain unclear for diabetic patients and need to be carefully investigated.
Strengths and Limitations
This study has several strengths. It provides an up-to-date literature review, which includes both
depression and suicidality as outcomes of interest among diabetic patients. It uses best practice
methods to help shed light on this very important and under-investigated topic. It provides
evidence that can be used as a reference point for future research focusing on specific diabetic
sub-populations. Finally, it takes into consideration several important factors (i.e. method of
depression evaluation, type of diabetes, whether diabetes was incident or prevalent, and
geographical location) in the analysis of our data, which adds to the robustness of this study.
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However, there are also several limitations we need to consider. First, there are few studies
assessing suicidality, especially attempted suicide. Second, there was a marked heterogeneity
among the included studies. Third, we included studies that used prescription of antidepressants
as a proxy for depression. This method is quite controversial especially among diabetic patients
since antidepressants are commonly used for symptomatic treatment of diabetic neuropathic pain,
which may falsely increase reported estimates. However, our subgroup analysis showed that
differences in depression evaluation methods did not significantly impact our results. Fourth,
confounding bias could not be entirely eliminated. Fifth, association of diabetes and suicidal
attempts and suicidal ideation do not imply causation. Finally, most studies included in our
systematic review were from developed countries and therefore, the results of our analysis need
to be interpreted with caution, as they may not be generalizable to the developing world.
Implications for future research and clinical practice
There are significant gaps and opportunities for research in this important public health topic.
Further research is warranted to: (a) examine the factors, mechanisms and transitional triggers
implicated in the association between diabetes, depression and suicidality; (b) assess the role and
impact of different diabetes management strategies on the patient’s risk of depression and
suicidality; and (c) evaluate the cultural and ethnic differences as they relate to diabetes,
depression and suicidality.
Clinicians should be aware and receive cross-training in order to be better prepared to address the
higher risk for depression and suicidality among diabetic patients. Additionally, several other
initiatives can be considered, including: (a) early detection and treatment of depression which
would improve diabetes control and consequently, delay the development of diabetic and
depression related complications; (b) there is a need to develop robust and standardized validated
screening tools for diabetic patients at risk for depression and suicidality; and (c) there is an
urgency to design and implement comprehensive interventions that take into account the complex




Our study found that diabetes is associated with an increased risk for depression, suicidal ideation
and suicidal attempts but not completed suicide. Therefore, efforts for early detection and
effective screening are urgently needed in primary care settings. Appropriate training for
healthcare providers in the field of suicidality screening and depression management would help
mitigate the negative impacts on a diabetic patient’s quality of life and reduce the growing burden
on healthcare systems. Given the limited number of studies on this important topic, further well-
designed studies are needed to confirm the findings of this meta-analysis.
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Table 2.2: Data from selected studies for systematic review and meta-analysis (depression studies)
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Sex and age by the case-control matching with added
adjustment for clinical depression.
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Table 2.5: Meta-regression for depression cohort studies
R2 reflects the amount of variability in I2 that is explained by the model.










depressants -0.026 -0.283 0.230
0.218 0.34
Disorders 0.126 -0.111 0.363
Level of
Adjustment* No
Full (>5) 0. 299 -0.126 0.726 0.386 0.1
Partial (<5) 0.024 -0.162 0.212
Female
Percent 0.023 -0.002 0.048 0.07 0
Diabetes PrevalentDiabetes
Incident





Asia 0.083 -0.155 0.032 0.111 0.36
Scandinavian -0.137 -0.375 0.101
Europe -0.147 -0.403 0.108
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Male 2 1.536 0.78 3.027 0.215 0.068 69.96
Female 2 2.097 0.971 4.528 0.059 0.232 29.89
Sex (adjusted) 0.696
Male 2 1.651 0.796 3.427 0.178 0.51 73.71
Female 2 2.059 0.895 4.733 0.089 0.21 36.34
Suicidal ideation
Type of diabetes 0.211
Type 1 2 1.306 0.637 2.678 0.464 0.01 84.75
Type 2 & not
specified
4 2.212 1.473 3.32 <0.001 0.032 70.82
Risk of bias 0.35
Low 2 3.435 0.849 13.898 0.084 <0.001 98.06
Moderate/high 4 1.371 1.005 1.872 0.047 0.032 70.83
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Figure 2.1: PRISMA flow chart for study selection process
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Figure 2.2: Forest plot for the odds ratio of the association between depression and diabetes
from cohort studies
Estimates are in the center of the box and lines represent 95% confidence intervals. Diamond
shows the pooled odds ratio size and its 95% confidence interval.
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Figure 2.3: Forest plot of unadjusted odds ratio for suicidality and diabetes
SA: suicidal attempts, SI: suicidal ideation. Red diamonds represent pooled odds ratio for each
outcome, while white diamond represent the overall odds ratio for the three outcomes.
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Figure 2.4: Funnel plots of the met-analysis of published studies.
Each point represents the log odds ratio and the standard error for a single study. The triangle
represents the region where 95% of the data points would lie in the absence of a publication bias.
The vertical line represents the average log odds ratio found in the meta-analysis.
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CHAPTER 3 - EXAMINING THE ASSOCIATION BETWEEN DIABETES, DEPRESSIVE
SYMPTOMS, AND SUICIDAL IDEATION AMONG INDIGENOUS CANADIAN PEOPLES
LIVING OFF-RESERVE: A CROSS-SECTIONAL, POPULATION BASED STUDY
3.1 Abstract
Background and rationale: Diabetes is a prevalent chronic condition that has been linked to
depression and suicidal behavior. The Indigenous peoples of Canada are known to suffer from
significant health disparities and higher burden of physical and mental illnesses. The purpose of
this study is to examine the association between diabetes, depression, and lifetime suicidal
ideation among Indigenous Canadian peoples living off-reserve.
Methods: Data were obtained from the Aboriginal Peoples Survey (APS), 2012. APS is a
national, cross-sectional survey of First Nations people living off-reserve, Métis and Inuit living
in Canada. A secondary analysis was conducted on a weighted sample of participants to assess
diabetes, depression and suicidal ideation. Descriptive statistics and multivariate logistic
regression analysis were conducted.
Results: Our study found that the prevalence of depressive symptoms was higher among
diabetics (15.67%) compared to non-diabetics (9.27%) (OR 1.82, 95% CI: 1.36- 2.44). After
adjusting for socio-demographic variables (aOR=1.64), smoking/alcohol use/drug use
(aOR=1.53), anxiety disorders and other chronic illnesses (aOR=1.52), diabetes was still
significantly associated with depressive symptoms (p-value= 0.0168). Additionally, diabetics
(23.86%) were more likely to report suicidal ideation compared to non-diabetics (18.71%) (OR
1.36, 95% CI: 1.05-1.77). Controlling for the effect of socio-demographics and health related
behaviors, diabetes was still associated with a higher risk (aOR=1.40) of reporting suicidal
ideation (p-value=0.0231).
Conclusions: Our results suggest that the Indigenous Canadian diabetic patients living off-
reserve are at higher risk for depressive symptoms and suicidal ideation. Culturally appropriate
co-screening strategies need to be implemented in primary healthcare settings to provide the
supports necessary for this vulnerable population. Further research is needed to fully elucidate the
nature of these associations in order to develop effective intervention and treatment approaches.
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3.2 Introduction
Indigenous peoples constitute diverse groups of the original inhabitants of Canada and their
descendants. According to the Canadian constitution, three major groups are recognized: First
Nations, Inuit, and Métis (1). In 2016, there were approximately 1.7 million Indigenous peoples,
representing 4.9% of the Canadian population. They represent one of the youngest and fastest
growing sub-segments of the Canadian population (2). The Indigenous Canadian peoples have
consistently shown high rates of diabetes, depression and suicidal behavior (3, 4, 5). In general,
diabetes has been linked to both depression and suicidal behavior (6, 7). However, research that
specifically examines these associations among Indigenous Canadian peoples is lacking.
The Indigenous Canadian peoples endure significant health disparities that lead to a higher
burden of diseases compared to their non-Indigenous counterparts (8, 9). These health disparities
are a by-product of socio-economic, cultural and political factors that negatively impact
Indigenous peoples. The socio-economic disadvantages stem from lower levels of education and
income, higher unemployment rates, and poor housing conditions (9). The political inequities
emerged as a consequence of colonization and resulted in the undermining of indigenous cultures
and values, marginalization and social exclusion (10). For instance, the historical trauma caused
by the Canadian government’s use of residential schools had a wide impact and serious
ramifications on Indigenous survivors and their descendants (10), which included: poorer general
and self-rated health, high rates of chronic illnesses, addictive behaviors, depression, and suicidal
behavior (11). The persistence and growth of these inequities ultimately resulted in health
disparities including poor physical and mental health among Indigenous peoples.
Indigenous peoples are particularly vulnerable and disproportionally affected by diabetes in
Canada (12). Diabetes, once considered rare among Indigenous communities, is now reported at
higher rates among First Nations living off-reserve (10.3%) and among Métis (7.3%) compared
to the general Canadian population (5%), and the gap is increasing (13). Even among Inuit people,
who historically have reported very low rates of diabetes, the trends are changing as their rates
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are becoming comparable to the general population (4.3%). These findings are mainly due to
poor dietary choices, limited physical activity, and increased obesity (14, 15). Indigenous
individuals are more likely to be diagnosed with diabetes at a younger age, suffer from serious
complications and experience worse treatment outcomes compared to non-Indigenous (16).
Moreover, under-reporting of the disease and limited access to healthcare services continues to be
a growing concern for the Canadian Indigenous peoples (17), suggesting the magnitude of the
diabetic epidemic may be larger than estimated (18).
Depression is a common co-morbidity with diabetes (6, 19, 20). Diabetic depressed patients are
less likely to adhere to medical treatment and lifestyle changes, resulting in poor prognosis for
both conditions (21). This co-morbidity has been widely examined in different populations but
there is scarcity of research among Indigenous peoples. In Canada, a study that assessed health
related quality of life found that Indigenous participants reported lower scores than non-
Indigenous and diabetes was more prevalent among Indigenous participants (22). It is known that
Indigenous peoples of Australia face health disparities that are similar to the Indigenous peoples
of Canada (23). A study in Australia evaluated the prevalence of depression among urban
diabetic patients and found it to be two times greater among the Indigenous compared to the non-
Indigenous population (24). The authors further reported that among Indigenous individuals,
depression tended to be more severe in nature and in many cases, undiagnosed and left untreated
(24).
Indigenous Canadian populations have one of the highest rates of suicide worldwide (25). Among
the First Nations, suicide rates are two times the national average and alarmingly, the Inuit
suicide rates are among the highest in the world (6 to 11 times the national average) (4). Suicidal
ideation is a crucial component of suicidal behavior, which often precedes suicidal attempts or
completed suicide, and is known to be a strong predictor for suicidal death (26). In 2012, 24% of
First Nations living off-reserve, 23.5% of Inuit, and 19.6% of Métis people reported lifetime
suicidal ideation compared to 11.1% in the general Canadian population (27). Similar to
depression, suicidal behavior has been linked to diabetes. However, the scientific evidence is
limited and at times, contradictory (7, 28) and therefore, more research is needed in this area.
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Despite Indigenous peoples in Canada consistently reporting higher prevalence of diabetes,
depression and suicidality, to the best of our knowledge, no studies explored the associations
between these conditions among this vulnerable population. Therefore, the aim of the present
study was to use data from the Aboriginal Peoples Survey (APS), 2012 to: (1) determine the
prevalence of depressive symptoms and suicidal ideation among patients with diabetes; (2)
investigate whether diabetes is associated with a higher risk of depression and suicidal ideation;
and (3) assess whether these associations vary by different characteristics among the Indigenous
Canadian populations living off-reserve.
3.3 Methods
3.3.1 Study characteristics
Design: Cross-sectional population based observational study.
Participants: The Indian reserve system is governed by the Indian Act (1876) and relates to the
First Nations people of Canada. Historically, First Nations people were legally bound by the
Canadian government to live on reserve. The ban was lifted in 1951 and First Nations were
allowed to live on or off-reserve (29). Presently, the majority (62%) of the First Nations
population live off-reserve, while the remaining portion (38%) live on-reserve (30). Métis and
Inuit people traditionally do not live on reserves. In this study, we are examining the off-reserve
Indigenous population (First Nations, Métis and Inuit) ages 15 years old or older.
Data source: The present study used data from the Aboriginal People Survey (APS) conducted
by Statistics Canada in 2012. It is a national survey on the social and economic conditions of
First Nations living off-reserve, Métis and Inuit. The APS had a participation rate of 76% and
used stratification-specific domains for sampling (31). To ensure that statistical estimates would
be representative of the Indigenous Canadian population, sampling weights computed by
Statistics Canada were incorporated into the analysis and the Taylor linearization method was




Measuring tool: Evaluation of depressive symptoms in this study was based on a modified
version of the K-10 distress scale. The K-10 scale is used to evaluate the distress experienced by
individuals during the past 30-days (32). The K-10 scale and a number of its modified versions
(K-5, K-6) have been previously used among Indigenous peoples (33, 34). While these tools
measure distress rather than depression or anxiety, their scores correlate well with depression and
anxiety (32). Self-reported suicidal ideation was part of the APS questionnaire.
Outcome measures
The main outcome measures for this study were depressive symptoms and lifetime suicidal
ideation.
Depressive symptoms: The present study used a modified version of the K-10 scale to assess
depressive symptoms among Indigenous participants. Six questions were selected and addressed
components of two domains that included: core symptoms (depressed mood and reduced energy)
and associated symptoms (unworthiness and hopelessness) (35). These questions were: “In the
past 4 weeks, about how often did you feel: (a) tired out for no good reason, (b) hopeless, (c)
depressed, (d) everything was an effort, (e) sad that nothing could cheer you up, and (f)
worthless?” Responses were ranked on a Likert scale: (a) all of the time, (b) most of the time, (c)
some of the time, (d) a little of the time, and (e) none of the time. To assess the reliability of these
questions, Cronbach’s was calculated, and found to be satisfactory (0.837). A mean score for
each respondent was calculated and adjusted for the number of questions answered. Participants
were dichotomized on the basis of a recommended cut-off value from the K-10 scale (32). Those
who scored 2.5 or greater were considered “depressed” while those with scores less than 2.5 were
“not depressed.”
Suicidal ideation: Lifetime suicidal ideation was assessed by asking the following question:
“Have you ever seriously considered committing suicide or taking your own life?” The answer
was either “yes” or “no”.
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Exposure variable
The main exposure variable was self-reported diabetes status. Diabetics were those respondents,
who answered “yes” to the following question: “We are interested in conditions diagnosed by a
health professional and that are expected to last or have already lasted 6-months or more. Do you
have diabetes?”
Control variables (covariates)
In the present study, socio-demographic, health related behavior, and clinical profile variables
were used as controls in our logistic regression models. Selection of these variables was based on
the recommendations made in the existing scientific literature (36).
Socio-demographic variables: These included, age (≤ 19, 20-34, 35-54, ≥ 55 years old), sex
(male or female), marital status (single, married, widowed/separated/divorced, living in common-
law), Aboriginal identity (First Nations, Métis, Inuit), highest level of education attained [(a)
grade 8 or lower/some secondary education; (b) secondary school diploma/some postsecondary
education; (c) postsecondary certificate or diploma below bachelor level; (d) bachelor’s degree/
university certificate or diploma or degree above bachelor level].
Health related behavior variables: These included, smoking status (daily, occasional, non-
smoker), alcohol use (regular, occasional, non-drinker) and drug-use (yes, no).
Clinical profile variables: These included, chronic illnesses [a derived variable that combined
responders who answered “yes” to one of the following questions: (“Do you have asthma,
fibromyalgia, learning disability, attention deficit disorder, chronic bronchitis, emphysema,
chronic obstructive pulmonary disease (COPD), intestinal or stomach ulcers, bowel disorder,
hypertension, heart disease and other physical or mental disorders”)] and anxiety disorders
[assessed using the following question: “Do you have an anxiety disorder such as a phobia,
obsessive-compulsive disorder or a panic disorder?” (yes, no)]. Additionally, for suicidal ideation,
mood disorders were included [as a covariate based on the question: “Do you have a mood
disorder such as depression, bipolar disorder, mania or dysthymia?” (yes, no)].
67
3.3.3 Statistical analysis
Initially, cross tabulations were performed examining the distribution of observations by
depressive symptoms, and suicidal ideation status for each variable. Due to data confidentiality
concerns, results are reported as rounded weighted frequencies. The unadjusted association
between diabetes and other covariates on depressive symptoms and suicidal ideation were
calculated using univariate binary logistic regression models. Covariates with p-value < 0.25,
qualified to be included in the multivariable logistic regression models.
For each outcome, four logistic regression models were constructed: Model 1 (crude unadjusted
associations between exposure and outcome variable), Model 2 (adjusts for the effect of socio-
demographic confounders), Model 3 (additionally adjusts for health related behavior), and Model
4 (additionally adjusts for clinical profile variables). If the p-value for a covariate was less than
0.05, the variable was retained in the multivariable model. Age and gender were considered
important confounders, and therefore, adjusted in the model irrespective of their p-values. The
Akaike Information Criterion (AIC) comparisons were used to compare the models (lower is
better).
Confounders and interaction assessment
To assess whether a covariate had a confounding effect, a change of 20% or more in the
coefficient of the main exposure variable (diabetes) was used as a cut-off (37). Effect
modifications were investigated by examining all possible two-way interactions for the main
exposure variable (diabetes) with predictors and confounders included in the main effect model.
Interactions were assessed based on their p-value and (AIC) comparisons.
Model diagnostics
The variance inflation factor (VIF) and tolerance for all variables were calculated to assess
whether multicollinearity (if present) would significantly affect reported estimates. We used a
cut-off at 2.5 for VIF and 0.4 for tolerance. For model predictability, the receiver operating
characteristic (ROC) curve was generated and the area under the curve (AUC) was measured and





The weighted total number of Indigenous participants who responded to the depression questions
was 963,110.The total mean score per participant ranged from 1 to 5 (1= least depressive
symptoms). The overall distribution of the mean score was right skewed as more participants
reported relatively low levels of depressive symptoms (median= 1.33). Of the participants, 8.34%
(n=80,350) were classified as having depressive symptoms. The prevalence of depressive
symptoms among those who reported a physician diagnosis of diabetes was 15.67% (n= 11,100),
compared to 9.27% (n= 69,070) among the non-diabetic participants. Table 3.1 depicts the
characteristics of the study participants, stratified by their depressive symptoms status.
1.1 Univariate analysis
Model 1: Diabetics were more likely to report depressive symptoms (OR= 1.82, 95% CI: 1.36-
2.44, p-value <0.0001) compared to non-diabetics. Additional crude estimates considering socio-
demographic variables showed that being female, middle aged, not married, lower levels of
education and First Nations was associated with significantly higher odds of reporting depressive
symptoms. Health related behavior variables showed that regular smokers, occasional alcohol
drinkers, and drug users had higher odds of depressive symptoms. Clinical profile variables
showed that having chronic illnesses other than diabetes and being diagnosed with an anxiety
disorder were the strongest predictors of depressive symptoms in our analysis. All variables had a
p-value < 0.25 in the univariate analysis. Table 3.2 lists the crude odds ratios and 95% confidence
intervals for the different covariates of depressive symptoms.
1.2 Multivariate analysis
Model 2: Our results indicated that the association between diabetes and depressive symptoms
remained significant after adjusting for socio-demographic variables (aOR=1.64, 95% CI: 1.17-
2.31, p-value=0.0043). There was no significant effect for Indigenous identity (p-value =0.1682)
and therefore, this variable was not included in model 3.
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Model 3: After adjusting for both socio-demographics and health related behaviors, diabetes
remained significantly associated with depressive symptoms (aOR=1.53, 95% CI: 1.12- 2.08, p-
value=0.0073). Interestingly, regular alcohol use had a significant protective effect against
depressive symptoms (p-value <0.0001). The odds of depressive symptoms for Indigenous
participants who reported regular use of alcohol were 44% lower than the odds of non-users
(aOR= 0.56, 95% CI, 0.44 – 0.71, p-value < 0.0001). Level of education was not a significant
predictor (p-value= 0.1094) and therefore, it was not included in model 4.
Model 4: Our results remained significant after further adjusting for clinical profile variables.
The odds of having depressive symptoms for patients with diabetes were 52% higher than those
reported for non-diabetics (aOR=1.52, 95% CI: 1.08-2.14, p-value=0.0168). Socio-demographic
variables showed that the odds for females were 1.5 times greater than those for males (aOR=1.5,
95% CI: 1.22-1.85, p-value =0.0001). Married participants had lower risk of reporting depressive
symptoms compared to single and divorced/separated/widowed individuals but not significantly
different from participants living in common-law relationships. Health related behaviors showed
that the odds of depression among daily smokers were 1.83 times greater than those of non-
smokers (aOR=1.83, 95% CI: 1.48-2.26, p-value <0.0001) but not different from those seen in
occasional smokers. Participants who reported use of drugs had 1.58 times greater odds of
depressive symptoms relative to non-users (aOR= 1.58, 95% CI: 1.23-2.03, p-value= 0.0003).
Focusing on clinical profile, being diagnosed with anxiety disorders was the strongest predictor
of depression (aOR= 4.16, 95% CI: 3.32- 5.22, p <0.0001). Respondents who reported having
other chronic illnesses were at higher risk of having depressive symptoms (aOR= 2.73, 95% CI:
2.15- 3.48, p-value <0.0001). Results of the multivariable analysis are shown in Table 3.3.
3.4.2 Suicidal ideation
The weighted total number of Indigenous participants who responded to the suicidal ideation
questions was 694,960. The overall prevalence of suicidal ideation was 19.08% (n=132,570). The
prevalence of suicidal ideation among diabetics was 23.86% compared to 18.71% among the
non-diabetic respondents. Table 3.4 depicts the characteristics of the study participants, stratified
by their suicidal ideation status.
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2.1 Univariate analysis
Model 1: Diabetics were more likely to report suicidal ideation (OR= 1.36, 95% CI: 1.05-1.77, p-
value =0.0193) compared to non-diabetics. Additional crude estimates considering socio-
demographic variables showed that being female, middle aged, unmarried and First Nations or
Inuit had significantly higher odds of reporting suicidal ideation. Health related behavior
variables showed smokers, non-alcohol users, and drug users had higher odds of suicidal ideation.
Clinical profile variables showed that chronic illnesses and mental disorders (anxiety and mood)
were the strongest predictors of suicidal ideation. Interestingly, the dichotomized depression
score (based on the modified K-10 scale) was strongly related to suicidal ideation; the odds of
experiencing lifetime suicidal ideation for those who were classified as having depressive
symptoms were 8.27 times higher than those who did not (95% CI: 6.8 - 10.05, p-value <0.0001).
Table 3.2 lists the crude odds ratios and 95% confidence intervals for the different covariates of
suicidal ideation.
2.2 Multivariate analysis
Model 2: After adjusting for socio-demographic variables, the association between diabetes and
suicidal ideation remained significant (aOR=1.44, 95% CI: 1.09-1.92, p-value=0.0117). Level of
education was not a significant predictor of suicidal ideation (p-value=0.1104) and therefore, it
was not considered in Model 3.
Model 3: The strength of association between diabetes and suicidal ideation was maintained
after adjusting for both socio-demographics and health related behavior variables (aOR=1.40,
95% CI: 1.05-1.88, p-value =0.0231). Once again, regular alcohol users were 41% less likely
(OR= 0.59, 95% CI: 0.49- 0.72, p-value <0.0001) to self-report suicidal ideation compared to
non-users. In this model, Indigenous identity was not a significant predictor of suicidal ideation
(p-value= 0.1856) and therefore, it was not included in Model 4.
Model 4: Our results found that the risk of suicidal ideation among diabetics was no longer
significant after additionally controlling for the effects of health related variables (aOR = 1.17,
95% CI: 0.87–1.56, p -value = 0.3012). Socio-demographic variables showed that individuals
aged between 35 and 54 years old had significantly higher risk of reporting suicidal ideation
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compared to individuals 55 years old or older (aOR= 1.23, 95% CI: 1.01- 1.64, p-value= 0.0385).
Consistent with our depression findings, being male, married or living in common-law
relationship was associated with significant lower risk of reporting suicidal ideation. Health
related behaviors showed that drug users (aOR= 2.82, 95% CI: 2.33- 3.42, p-value< 0.0001) and
daily smokers (aOR= 1.39, 95% CI: 1.17- 1.64, p-value= 0.0001) are at higher risk of suicidal
ideation, while regular alcohol use maintained its protective effect. Clinical profile variables
showed that mood disorders were the strongest predictor of suicidal ideation (aOR= 4.64, 95% CI:
3.77-5.72). Participants diagnosed with anxiety disorders (aOR= 1.52, 95% CI: 1.22- 1.88) or
other chronic illnesses (aOR= 1.73, 95% CI: 1.44- 2.07) were more likely to report suicidal
ideation compared to those who were not. Table 3.6 illustrates results of the multivariable
analysis with suicidal ideation as the outcome of interest.
3.5 Discussion
In the present study, we examined the association between diabetes, depression, and lifetime
suicidal ideation in a national sample of the Indigenous Canadian peoples living off-reserve. Our
data show that Indigenous diabetics are at a significantly higher risk for experiencing depressive
symptoms compared to their non-diabetic counterparts. That effect maintained its strength after
adjusting for socio-demographics, health related behaviors and clinical profile factors.
Furthermore, our results indicated that diabetes was associated with a higher risk for suicidal
ideation, when considering socio-demographic and health related behavioral factors.
The crude prevalence of depressive symptoms among Indigenous diabetic participants was
15.67% compared to 9.27% among non-diabetics. Our study findings corroborate those reported
by Davis et al., who examined depression among Indigenous Type 2 diabetic patients in Australia.
They found prevalence rates to be higher than those reported among the general Australian
population (24). However, other studies contradict our findings. One of these studies assessed
depression (and other factors) among Canadian Indigenous participants with impaired glucose
tolerance and Type 2 diabetes. They found no difference in the prevalence between the diabetic
and pre-diabetic group compared to the normo-glycemic group. Yet, this study suffered from a
number of limitations including a high risk of selection bias and limited study power (38).
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The high prevalence of depression observed in our study is concerning, especially when one
considers the findings reported in the literature that help highlight the lack of attention to
depression screening and management among Indigenous diabetic patients in primary healthcare
settings (34, 39). Therefore, it is not surprising to note the many negative consequences of
untreated depression, especially in the cases of Indigenous diabetics, which may manifest as
higher burdens of disability, increased cost of hospitalization and even premature death (40).
Our results show that diabetes was independently associated with higher risk for experiencing
depressive symptoms, even after adjusting for all control variables. This finding supports the
growing body of literature that suggests that diabetes and depression are related (6, 19, 20, 41,
42). There is evidence of a bidirectional association whereby diabetes increases the risk of
depression (6, 19, 20) and depression increases the risk of diabetes (41, 42). Given the
exploratory, cross-sectional nature of our study, our results confirm the existence but are unable
to determine the directionality of this association.
Among the more plausible explanations for the association between diabetes and depression
among the Indigenous Canadian population is the role played by socio-economic status (SES). In
general, SES is a strong predictor of both diabetes and depression (43-45). SES plays an
important role as diabetes is known to be inversely related to the level of income, education, and
housing (46, 47). Within the Canadian Indigenous context, the social, cultural and economic
inequities experienced by this population, adversely impact their SES (48). Their continued
struggle to meet basic needs with limited resources, disadvantageous conditions and risky
behaviors (e.g. smoking, alcohol drinking and drug use) impose high levels of chronic stress (49)
that may lead to the development of diabetes, depression and suicidal behavior (50, 51).
In our study, the prevalence of lifetime suicidal ideation among Indigenous diabetics was 23.86%
compared to 18.71% in non-diabetic respondents. Controlling for the differences in socio-
economic and health related behavioral factors; diabetes was a statistically significant predictor
of suicidal ideation, which is in concordance with previous studies (52, 53). This finding may not
be surprising as depression is a strong risk factor for suicidal behavior (54) and therefore, it can
act as a mediating step in the association between diabetes and suicidal behavior (55).
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Nevertheless, when considering the problems of diabetes and suicidal ideation in the Indigenous
population of Canada, historical context cannot be ignored. For example, the effect of the
traumatic experiences of Indigenous peoples in residential schools has been linked to both
suicidal behavior and diabetes (56, 57). It was demonstrated that the structural violence practiced
in residential schools not only increased the risk of suicidal behavior among the schools’
attendees, but also their descendants by suffering from “intergenerational trauma” (56).
Additionally, these institutions suppressed indigenous dietary practices and replaced traditional
healthy foods with western foods that are high in salt, sugar and fat (57). These unhealthy dietary
practices were maintained in later generations (57) and may have contributed to the epidemic of
diabetes in the Indigenous population.
It is interesting to note that, in our results, regular alcohol use was associated with a significant
protective effect for depressive symptoms and suicidal ideation. This finding seems to contradict
those previously published in the literature. These studies mainly focused on heavy and
hazardous use of alcohol and found a positive association with depression and suicidal behavior
(58, 59, 60). Other studies have also described a J shaped relationship, whereby regular low-to-
moderate drinkers have experienced lower risk of depression relative to abstainers (61, 62).
Several explanations for this pattern have been proposed, which include: (a) a direct protective
effect of alcohol on depression, similar to its effect on coronary heart disease (63); and (b) social
aspects of alcohol use related to drinking behavior, whereby in certain cultures, low-to-moderate
regular drinkers may psychologically benefit by becoming better socially adjusted compared to
those who never drink alcohol (61). However, our study findings should be interpreted with
caution since key details in alcohol use were not available (e.g. frequency, quantity, volume,
duration) among our participants, which could significantly change the pattern of the inter-
relationship between alcohol use, depression and suicidal behavior (64).
Strengths and limitations
This study has several strengths, which include: (a) a large, representative, national sample, (b)
use of weights to statistically adjust our sample, which resulted in the generalizability of our
findings among the Indigenous Canadian population living off- reserve; (c) adjusting for a wide
variety of factors (socio-demographic, health related behavior, and clinical profile variables); and
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(d) participants were not recruited based on their diabetes, depression, or suicidal ideation status,
therefore, the potential for selection bias was minimal.
This study also has some limitations: (a) the cross-sectional design is helpful in identifying the
associations between diabetes, depression and suicidal ideation, but cannot be used to infer
directionality and causality; (b) the use of self-report survey data may be prone to recall bias and
social desirability but the validity of the survey has been well established (31); (c) due to the
sensitivity of the topics and possible stigmatization, there is a possibility that participants with
depression or suicidal ideation either did not participate in the survey or did not accurately
respond to particular questions, and (d) according to Statistic Canada, the sample used for the
suicidal ideation question may not be representative for those younger than 18 years old and
therefore, caution is required in interpreting the findings.
Implications for research and clinical practice
This study provides previously unavailable information about diabetes, depression and suicidal
ideation in the Indigenous Canadian population living off-reserve. It underscores the need to
improve awareness among diabetic patients and healthcare providers on the common co-
occurrence of these conditions. It also highlights the importance of depression and suicidal
behavior screening for diabetic patients in primary healthcare settings. Screening and
management of depression and suicidal behavior is complicated in Indigenous patients due to
cultural differences that can represent a barrier to effective screening. Therefore, when
developing and implementing health policies and health promotion initiatives to address
depression and suicidal behavior among Indigenous diabetics, focus should be given on culturally
sensitive and acceptable strategies.
Further research is needed to understand the potential biological and psychological mechanisms
implicated in the association between depression and suicidal behavior in patients with diabetes.
Longitudinal studies are required to characterize risk factors, identify the course and effect of co-
morbidity and assess how it relates to prognosis and response to treatment. It is essential when
conducting research with Indigenous peoples to use an intersectional approach to study the
interplay between different social, political and cultural factors. Future research that examines the
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patterns of alcohol use among Indigenous diabetic patients and its effect on development of
depression and suicidal behavior is required.
3.6 Conclusions
Our study found that the Indigenous Canadian diabetic population living off-reserve is at a higher
risk of experiencing depressive symptoms and suicidal ideation compared to non-diabetics.
Raising awareness, improving the training of healthcare professionals and developing culturally
appropriate co-screening strategies are important steps in reducing the burden of depression and
suicidal behavior among Indigenous diabetics. Such co-screening efforts can help in the early
identification and management of these complex cases and decrease the burden of further
disability, hospitalization and premature death. Future research is required to elucidate the
temporal nature of the association between diabetes, depression and suicidal ideation among the
Indigenous peoples of Canada.
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Table 3.1: Characteristics of study participants based on depression symptoms




















































































































































* Rounded weighted frequency
Bachelor’s degree/
university certificate






































































































≤ 19 years 0.29 0.22 0.38 <0.0001
20-34 years 1.20 0.92 1.58 0.1808
35-54 years 1.43 1.09 1.87 0.0097
Sex
(Ref: Male)
Female 2.07 1.72 2.49 <0.0001
Marital Status
(Ref: Married)
Single 1.75 1.68 1.82 <0.0001
Widowed/separated/
or divorced
2.77 2.71 2.84 <0.0001
Common law 1.56 1.16 2.08 0.0029
Aboriginal Identity
(Ref: Métis)
First Nations 1.22 1.02 1.45 0.0296
























Daily 3.03 2.56 3.70 <0.0001
Occasional 1.79 1.63 2.03 0.0003
Alcohol use
(Ref: Non-drinker)
Occasional 1.38 1.08 1.77 0.0098
Regular 1.05 0.84 1.29 0.6828
Drug use
(Ref: No)




Yes 7.45 6.03 9.20 <0.0001
Anxiety disorders
(Ref: No)
Yes 7.78 6.41 9.43 <0.0001
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Table 3.3: Adjusted odds ratios (with 95% confidence intervals) of depressive symptoms


















































































<0.0001 - - - -
Inuit 0.92
(0.69- 1.19)





























Model 2: Adjusts for age, sex, marital status, aboriginal identity, and level of education.
Model 3: Adjusts for age, sex, marital status, level of education, smoking, alcohol use, and drug use.

















































Yes - - - - 4.16
(3.32-5.22)
<0.0001
AUC 0.653 0.673 0.768
85
Table 3.4: Characteristics of study participants based on suicidal ideation status







































































































































































































































































≤ 19 years 0.89 0.69 1.12 <0.0001
20-34 years 1.45 1.17 1.81 0.0019
35-54 years 1.71 1.38 2.12 <0.0001
Sex
(Ref: Male)
Female 1.45 1.26 1.68 <0.0001
Marital Status
(Ref: single)
Married 0.592 0.495 0.707 <0.0001
Widowed/separated/
or divorced
1.345 1.083 1.670 <0.0001
Common-low 0.908 0.745 1.107 0.8312
Aboriginal Identity
(Ref: Métis)
First Nations 1.26 1.08 1.46 0.2554
























Daily 2.25 1.93 2.62 <0.0001
Occasional 1.42 1.11 1.81 0.6388
Alcohol use
(Ref: Non drinker)
Occasional 0.95 0.77 1.17 0.3114
Regular 0.75 0.63 0.89 0.0003
Drug use
(Ref: No)




Yes 3.36 2.88 3.91 <0.0001
Anxiety disorders
(Ref: No)
Yes 4.89 4.09 5.87 <0.0001
Mood disorders
(Ref: No)
Yes 8.993 7.537 10.729 <0.0001
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Table 3.6: Adjusted odds ratios (with 95% confidence intervals) of suicidal ideation
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0.0337 - - - -
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Model 1: unadjusted
Model 2: Adjusts for age, sex, marital status, aboriginal identity, and level of education.
Model 3: Adjusts for age, sex, marital status, aboriginal identity, smoking, alcohol use, and drug use.







0.0384 - - - -
Smoking
(Ref: Non smoker













































AUC 0.602 0.675 0.768
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CHAPTER- 4: CONCLUSION
This section provides an overview of the study objectives, highlights the methodological
approaches used, and offers insight and a brief discussion of the key findings. Finally, it discusses
strengths and limitations and notes relevant implications for public health practice and
opportunities for future research.
4.1 Overview of study objectives
Diabetes, depression and suicidal behavior are increasingly prevalent conditions with major
public health implications (1, 2, 3). A potential association between diabetes, depression, and
suicidal behavior has been suggested but not entirely explored (4, 5). Therefore, there is a need
for a systematic appraisal of current epidemiological evidence to collectively assess the risk of
depression and suicidality in patients with diabetes.
The Indigenous Canadian population is facing a growing epidemic of diabetes, depression and
suicidal behavior (6,7). Yet, this vulnerable population is consistently under-represented in
research studies that aim to address mental health issues among patients with diabetes. Current
knowledge on the extent of the problems of depression and suicidality (specifically, suicidal
ideation) among Indigenous diabetic patients is lacking.
Therefore, this thesis aims to address two main objectives: (1) to systematically evaluate the
association between diabetes, depression, and suicidal behavior among the general population
(Chapter 2); and (2) to assess that inter-relationship between diabetes, depression, and lifetime
suicidal ideation among Indigenous Canadians living off-reserve (Chapter 3).
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4.2 Methodology and key findings
Chapter 2
A systematic literature review and meta-analysis was conducted to evaluate the risk of depression
and suicidality among diabetic patients. Our systematic review methodology closely followed the
guidelines outlined in the Preferred Reporting Items for Systematic Reviews and Meta-Analyses
(PRISMA). PRISMA is an evidence-based checklist that is used to ensure: (a) transparency of the
study selection process; (b) accurate presentation of the study findings; and (c) high quality
reporting of the systematic reviews and meta-analyses (8). Five databases were searched for
relevant studies. Two reviewers assessed eligibility based on pre-specified inclusion and
exclusion criteria to limit the potential for a selection bias. Meta-analysis was used to provide a
quantitative synthesis of data and to obtain integrated pooled estimates from the different studies.
A total of 5,750 articles were identified, of those 33 reporting data only on depression, 14 only on
suicidality, and three studies reporting data on both depression and suicidality among diabetic
patients. Our meta-analysis found that diabetic patients were at a significantly higher risk of
depression compared to non-diabetics (p-value <0.001). In cross-sectional studies, among
patients with diabetes, the odds of depression were twice as high as those reported in non-
diabetics (OR=2.04, 95% CI: 1.73-2.42). Likewise, in cohort studies, the odds of depression in
diabetic patients were 1.5 times greater than those of non-diabetics (OR=1.48, 95% CI: 1.36-
1.65).
Our meta-analysis also assessed the prevalence of suicidal behavior among patients with diabetes.
We found the pooled prevalence of suicidal ideation, attempts, and completed suicide to be
16.2%, 2.7%, and 0.3%, respectively. Additionally, patients with diabetes were at a significantly
higher risk for experiencing suicidal ideation (OR of 1.89, 95% CI: 1.36- 2.63) and attempting
suicide (OR 1.45, 95% CI: 1.07- 1.96). Finally, there was not enough evidence to support an




Epidemiological analysis and modeling of secondary data was used to examine the association
between diabetes, depressive symptoms, and lifetime suicidal ideation in a national sample of the
Indigenous Canadian peoples living off-reserve. In this study, we used data from the Aboriginal
Peoples Survey (APS, year 2012), which is a national, cross-sectional survey of Indigenous
peoples living off-reserve. A modified version of the K-10 distress scale was used to evaluate
depressive symptoms, whereas diabetes and suicidal ideation were self-reported.
In this study, several multivariable logistic regression models were sequentially constructed,
where diabetes represented the exposure of interest, while depressive symptoms and suicidal
ideation were considered as the main outcomes. These models adjusted for different groups of
confounders, which included: socio-demographics, health related behaviors, and clinical profile
factors. Meanwhile, the recommended use of weights to statistically adjust our sample resulted in
the generalizability of our findings among the Indigenous Canadian population living off- reserve
The total number of Indigenous participants who responded to the depression questions was
963,110. Our study results found the prevalence of depressive symptoms in the Indigenous
diabetics to be 15.67% compared to 9.27% among the non-diabetic participants. After adjusting
for socio-demographic variables (aOR=1.64, 95% CI: 1.17-2.31), smoking/alcohol use/drug use
(aOR=1.53, 95% CI: 1.12- 2.08), anxiety disorders and other chronic illnesses (aOR=1.52, 95%
CI: 1.08-2.14), diabetes was still significantly associated with depressive symptoms (p-value=
0.0168).
The total number of Indigenous participants who responded to the suicidal ideation question was
694,960. Our study results found the prevalence of suicidal ideation in diabetics to be 23.86%
compared to 18.71% among the non-diabetic participants. After adjusting for the effect of socio-
demographic variables (aOR=1.44, 95% CI: 1.09-1.92) and health related behavioral factors
(aOR=1.4, 95% CI: 1.05-1.88), diabetes was still significantly associated with a higher risk of
reporting suicidal ideation (p-value=0.0231). However, after further adjusting for mental
disorders (mood and anxiety) and other chronic illnesses (aOR = 1.17, 95% CI: 0.87–1.56), the
association was no longer significant (p-value = 0.3012). It was interesting to note that in our
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results, regular use of alcohol had a significant protective effect on both depressive symptoms
and suicidal ideation.
4.3 Interpretation of our findings
Chapter 2
Our systematic review and meta-analysis findings reinforce the evidence for an association
between diabetes and depression (4, 9). Specifically, our results (based on the included cohort
studies) support temporality and suggest a causal association linking diabetes to subsequent
development of depression. This finding is not entirely surprising, as there are several plausible
psychological and biological explanations that help account for this association. Psychological
explanations may include: the demanding nature of diabetes self-management, major lifestyle
modifications, and the increased concern among patients of suffering from possible diabetic-
related complications and disability (10). Biological contributors may include: activation of the
hypothalamic pituitary adrenal axis, changes to blood flow, and chronic inflammation (11, 12).
Our study found that diabetic patients were at a significantly higher risk for suicidal ideation and
attempted suicide compared to non-diabetics. The fact that depression is a strong risk factor for
suicidality may help explain the increased risk of suicidal ideation and attempted suicide in
diabetic patients (13). Still, it is important to highlight that diabetics were more prone to not only
consider suicide (suicidal ideation) but also had an increased likelihood to progress to suicidal
attempts. This finding is concerning in light of the fact that diabetic patients have ready access to
anti-diabetic medications that could be (mis)used as a means of committing suicide. However, it
should be noted that our study found no difference in the risk for completed suicide between
diabetic and non-diabetic individuals. This finding may be attributed to several factors, including:
(a) the many barriers to accurate assessment and reporting of suicidal deaths; and (b) the




Our study found that Indigenous diabetic patients were at a significantly higher risk for
depressive symptoms and suicidal ideation compared to non-diabetics. The strength of this
association was maintained even after adjusting for several confounders, suggesting that these
factors could not fully account for the co-occurrence of diabetes, depressive symptoms and
suicidal ideation. These results are concerning, especially when considering that Indigenous
diabetic patients are under-screened and under-treated for depression in primary healthcare
settings (14,15). This finding may be better understood within the historical context and socio-
political struggles of the Canadian Indigenous peoples. Among those factors, the disadvantageous
socio-economic conditions and traumatic historical experiences (e.g. residential schools) have
played a critical role in causing severe heath disparities and may be associated with a higher risk
of diabetes, depression and suicidal behavior among Indigenous peoples. Further research into
the links of these important and culturally sensitive health topics is needed.
In this study, differences in mental disorders (anxiety and mood) and chronic illnesses accounted
for the increased risk of suicidal ideation among diabetics. This may be due to the fact that
diabetes is associated with a much higher burden of mental disorders and chronic illnesses
(16,17). Therefore, mental disorders and chronic illnesses can act as mediating factors in the
pathway of the association between diabetes and suicidal ideation.
In our results, there was an indication of a protective effect for regular alcohol use against
depression and suicidal behavior. Some suggestions to explain this effect include: (a) a direct
protective effect for alcohol; and (b) the social aspects involved in alcohol drinking may enhance
the psychological well-being of moderate regular drinkers compared to abstainers (18). However,
this finding should be interpreted with caution, as some key details in alcohol use were not
available (i.e. frequency, volume, duration), which can significantly modify the association
between alcohol use, depression and suicidal behavior.
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Comparative findings
Comparing findings from our cross-sectional study (assessing Indigenous participants) to the
systematic review and meta-analysis (reflective of the general population) yielded some
additional important outcomes. The risk of depressive symptoms among Indigenous diabetic
individuals (OR= 1.82) was relatively higher than the one calculated in our subgroup meta-
analysis (based on the cross-sectional studies assessing depressive symptoms) (OR=1.47). Given
the novelty of the tool used to evaluate depressive symptoms in our study, the findings may not
be generalizable. However, it is also likely that Indigenous diabetic individuals may suffer a
higher burden of depression compared to the general diabetic population, possibly due to the
associated health disparities and socio-political struggles faced by this vulnerable population.
Surprisingly, the risk of suicidal ideation among our Indigenous diabetic study participants (OR=
1.36) was relatively lower than the one calculated among the general population in our meta-
analysis (OR=1.89). To understand this finding, one needs to consider several factors, which may
include differences: (a) in the suicidal ideation assessment tools used by the various studies, (b)
in the assessment period between our meta-analysis studies (assessed short-term suicidal ideation
from two to four weeks) and our cross-sectional study (assessed lifetime suicidal ideation); (c) in
the social perception, negative stereotypes and stigmatization associated with the Indigenous
peoples and suicidal behavior. To examine this possibility, an additional (post-hoc) analysis was
conducted, where we found that Indigenous diabetic patients were more likely to skip or refuse to
answer the suicidal ideation question compared to non-diabetic participants. Thus, additional
research is needed to explore this culturally sensitive and complex topic.
4.4 Strengths and Limitations
Chapter 2
The major strengths of our systematic review and meta-analysis are reflected in its collective
examination of depression and suicidality as outcomes of interest and the statistical evaluation of
a variety of factors among 50 studies. The most prominent limitations centered on the statistical




The major strengths of our secondary analysis were the use of a large national sample of the
Indigenous Canadian population and the construction of sequential multivariable models.
Modeling was used to help examine the independent association between diabetes, depressive
symptoms and suicidal ideation while adjusting for a variety of factors (socio-demographic,
health related behavior, and clinical profile variables). The most prominent limitations centered
on the use of self-report data, which may lead to under or over-reporting of responses and the
lack of validation studies for our modified K-10 scale (used to assess depressive symptoms),
which may impact the generalizability of our findings.
4.5 Implications for public health practice
Chapter 2
Although the problems of depression and suicidal behavior in patients with diabetes are serious
and concerning, significant improvements can be made using integrative interventions that create
a multifaceted partnership between diabetic patients, healthcare providers, policy makers, and the
healthcare system. It is reported that the majority of diabetic patients are mainly seen and
managed in primary care settings. However, it has been shown that comprehensive depression
screening and treatment in these settings occurs infrequently and is less than optimal (19). This is
due to the fact that diabetic patients and healthcare providers mutually prioritize addressing the
physical health needs first and foremost rather than mental health (14).
Therefore, health promotion initiatives among diabetic patients should focus on reducing mental
health stigma and raising awareness on the importance of discussing their mental health concerns
during regular follow-up visits with their physicians. Training of primary healthcare providers is
crucial to: (a) overcome poor knowledge and increase awareness of the common co-occurrence of
diabetes, depression and suicidal behavior; and (b) familiarize them with depression and suicidal
behavior screening tools and management strategies. Policy makers and clinical practice
recommendations need to emphasis the importance of regular psychological screening especially
for high-risk groups such as diabetics. The healthcare system should work on: (a) integration of
services and improvement of referral networks; and (b) enhancing the role of nurses and allied
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healthcare professionals in mental health services, especially in remote and rural areas.
Chapter 3
Despite the high rates of depression and suicidal behavior among Indigenous Canadian diabetics,
they are less likely to seek mental health services. Indigenous patients lack trust in the western
mainstream approaches to medical management and treatment of many diseases, including
diabetes and mental disorders. Additionally, mainstream medical approaches ignore the holistic
Indigenous view of health and wellness. Therefore, integration of traditional Indigenous
knowledge should be a key component in all interventions targeting the health of Indigenous
peoples.
Similarly, healthcare providers should seek to receive culturally appropriate training to improve
their communication skills with Indigenous patients. The healthcare system should support
collaboration with community leaders and engagement of communities to build trust and increase
knowledge about the high risk of depression and suicidal behavior among Indigenous diabetic
patients. Finally, given the complexity of the problem of depression and suicidal behavior among
Indigenous diabetic patients, collaborative and interdisciplinary efforts aimed at early
identification and management may help improve treatment outcomes and decrease the disability
associated with these conditions.
4.6 Future research
Chapter 2
Identification of modifiable risk factors that contribute to the associations between diabetes,
depression and suicidal behavior would help in the design and development of comprehensive
intervention strategies. Research that focuses on the characterization of distinctive predictive
factors for suicidal death, in addition to suicidal ideation or attempts is warranted.
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Chapter 3
Future research is needed to examine the associations between diabetes, depression and
suicidality among the Indigenous Canadian population living on-reserve. Research that assesses
the correlation between the modified K-10 scale (used in our study) and the clinical diagnosis of
depressive disorders is required. Since this scale represents a new tool that is short, easy to
administer, and shown to be acceptable among Indigenous peoples, it could potentially be used
for depression screening in primary healthcare settings. Finally, there is a need to examine the
role and mechanism of diabetes in the development and progression of depression and suicidal
behavior both in the general and the Indigenous Canadian population.
4.7 Conclusion
This thesis addressed an important and yet under-investigated research topic concerning the
association between diabetes, depression, and suicidal behavior. It used different sets of
analytical tools and investigative methods (systematic review and meta-analysis and secondary
data analysis) to evaluate the associations of interest both in the general and the Indigenous
Canadian populations. We found that diabetic patients were at an increased risk for depression
and suicidal behavior compared to non-diabetics.
Integrative, multifaceted interventions that involve diabetic patients, healthcare providers, and the
healthcare system are needed. Implementation of effective screening and management strategies
for depression and suicidal behavior among Indigenous peoples and the wider population could
help mitigate their negative impact on a diabetic patient’s quality of life and reduce the growing
burden on the healthcare system. It is important to note that this research work is exploratory in
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APPENDIX 1- NEWCASTLE OTTAWA QUALITY ASSESSMENT SCALE
A. Case-control Studies
Note: A study can be awarded a maximum of one star for each numbered item within the
selection and exposure categories. A maximum of two stars can be given for Comparability.
Selection
1) Is the case definition of depression or suicidality adequate?
a) Yes, with clinical evaluation, ICD code, or record linkage*
b) Yes, based on supervised self-reports (questionnaires)*
c) Based on unsupervised self-report
d) No description
2) Representativeness of the cases of depression and suicidality
a) Consecutive or obviously representative series of cases*
b) Potential for selection biases or not stated




4) Definition of Controls
a) No history of depression (endpoint)*
b) No description of source
Comparability
1) Comparability of cases and controls on the basis of the design or analysis
a) Study controls for demographic variables*
b) Study controls for any additional factor*
Exposure
1) Ascertainment of exposure
a) Secure record (e.g. medical records)*
b) Structured interview where blind to case/control status or lab test*
c) Interview not blinded to case/control status
d) Written self-report or medical record only
e) No description
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a) Same rate for both groups*
b) Non-respondents described








Good ≥3 3 2
Fair 1-2 2 1
Poor 0 0-1 0
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B. Cohort Studies
Note: A study can be awarded a maximum of one star for each numbered item within the
Selection and Outcome categories. A maximum of two stars can be given for Comparability
Selection
1) Representativeness of the exposed cohort
a) Truly representative of the average diabetic in the community*
b) Somewhat representative of the average diabetic in the community*
c) Selected group of users e.g. nurses, volunteers
d) No description of the derivation of the cohort
2) Selection of the non-exposed cohort
a) Drawn from the same community as the exposed cohort*
b) Drawn from a different source
c) No description of the derivation of the non-exposed cohort
3) Ascertainment of exposure (diabetes)









1) Comparability of cohorts on the basis of the design or analysis
a) Study controls for demographic variables*
b) Study controls for any additional factor*
Outcome
1) Assessment of outcome
a) Clinical diagnosis*
b) Record linkage*




2) Was follow-up long enough for outcomes to occur?
a) Yes (1 yr.)*
b) No
3) Adequacy of follow up of cohorts
a) Complete follow-up - all subjects accounted for*
b) Subjects lost to follow up unlikely to introduce bias - small number lost - > 20 follow up,
or description provided of those lost)*









Good ≥3 3 2
Fair 1-2 2 1




1) Representativeness of the exposed (diabetic) group
a) Truly representative of the target population in the community*
b) Somewhat representative of the target population in the community*
c) Selected group of users e.g. nurses, volunteers
d) No description of the derivation of the group
2) Ascertainment of exposure (diabetes) status








1) Assessment of outcome
a) Clinical diagnosis*
b) Record linkage*
c) Structured interview or applied questionnaire*
d) Self-report (questionnaire)
e) No description
2) Completeness of outcome measure across groups
a) Complete outcome measures for all subjects (not greater than 5% missing)*
b) Missing outcome measures handled with appropriate methods e.g. imputation*












Study Risk of Bias Domain
Low Good quality in all domains
Unclear/moderate Fair quality in one or more domains
without Poor quality
High Poor quality in any domain
